Listed

Colgate Palmolive Co: Form 10-Q for the period ended Sep 30, 2021

Filed with the SEC on Oct 29, 2021 and accepted by EDGAR at Oct 29, 2021, 08:52 ET.

Share

Management's discussion and analysis

As filed, 1,957 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months ended September 30, 2021:

Month Total Number of Shares Purchased(1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions)
July 1 through 31, 2021 731,516 $82.62 705,454 $1,071
August 1 through 31, 2021 1,305,856 $78.56 1,304,000 $968
September 1 through 30, 2021 1,032,307 $76.93 984,150 $892
Total 3,069,679 $78.98 2,993,604

(1) Includes share repurchases under the 2018 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

(2) The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 76,075 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.

(3) Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of September 30, 2021.

Risk factors

As filed, 182 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors disclosed in Part 1, Item 1A. Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-07-01 to 2021-09-30$4.41bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2021-01-01 to 2021-09-30$13.02bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-07-01 to 2021-09-30$1.79bnus-gaap:CostOfRevenue
Cost of revenue9 months2021-01-01 to 2021-09-30$5.20bnus-gaap:CostOfRevenue
Gross profit3 months2021-07-01 to 2021-09-30$2.62bnus-gaap:GrossProfit
Gross profit9 months2021-01-01 to 2021-09-30$7.82bnus-gaap:GrossProfit
Selling, general and administrative3 months2021-07-01 to 2021-09-30$1.64bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2021-01-01 to 2021-09-30$4.81bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-07-01 to 2021-09-30$967.0mus-gaap:OperatingIncomeLoss
Operating income9 months2021-01-01 to 2021-09-30$2.97bnus-gaap:OperatingIncomeLoss
Income tax3 months2021-07-01 to 2021-09-30$172.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2021-01-01 to 2021-09-30$613.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-07-01 to 2021-09-30$634.0mus-gaap:NetIncomeLoss
Net income9 months2021-01-01 to 2021-09-30$2.02bnus-gaap:NetIncomeLoss
Diluted EPS3 months2021-07-01 to 2021-09-30$0.75us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2021-01-01 to 2021-09-30$2.38us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-07-01 to 2021-09-30$0.75us-gaap:EarningsPerShareBasic
Basic EPS9 months2021-01-01 to 2021-09-30$2.39us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-07-01 to 2021-09-30846,400,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2021-01-01 to 2021-09-30849,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2021-01-01 to 2021-09-30$2.22bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2021-01-01 to 2021-09-30$374.0mus-gaap:PaymentsToAcquireProductiveAssets
Share repurchases9 months2021-01-01 to 2021-09-30$964.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2021-09-30$958.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-09-30$4.67bnus-gaap:AssetsCurrent
Total assetsAt period end2021-09-30$15.88bnus-gaap:Assets
Current liabilitiesAt period end2021-09-30$4.28bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-09-30$14.85bnus-gaap:Liabilities
Long-term debtAt period end2021-09-30$7.68bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-09-30$11.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2021-09-30$591.0mus-gaap:StockholdersEquity
Shares outstandingAt period end2021-09-30842,848,691 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000021665-21-000027. Last ingested by Listed: Nov 13, 2026, 16:05 ET. Listed shows no prices and gives no investment advice.